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Keratinocytes produce large amounts of 1,25 dihydroxyvita-
min D3 (1,25(OH)zD3) il1 vitro. 1,25(OH)zD3 is detectable 
in anephric humans and pigs and can be increased to near-
normal levels by vitamin D or 250HD, indicating an extrare-
nal source. To determine whether the skin is one of these 
extrarenal sources, we perfused isolated flaps of porcine skin 
for 8 h with 250HD3 in serum-free medium at 1 ml/min, 
collecting the venous effluent as 15-min samples. The sam-
ples were extracted and the vitamin D metabolites purified by 
high-performance liquid chromatography and assayed by 
competitive protein-binding techniques. Production of 
1,25(OH)2D3 continued for the duration of the perfusion, 
tending to increase in the last 2 hours. The amount of 
1,25(OH)2D3 produced varied both with time in the same 
Keratinocytes are not only capable of producing vita-min D,(D,) from endogenous sources of 7 -dehydro-cholesterol (7-DHC) [1,2], they are also capable of producing a variety of D metabolites including 1,25 dihydroxyvitamin D, (1,25(OHhD3), 24,25 dihy-
droxyvitamin D3 (24,25(OH)2D3)' and 1,24,25 trihydroxyvitamin 
D3 (1 ,24,25(OHhD,) [3 - 5] from exogenous sources of 25 hydrox-
yvitamin D, (250HD3) . Production of 250HD, from D, does not 
seem to take place in keratinocytes [6]. Regardless of whether the 
keratinocyte depends on endogenous or exogenous sources of 
250HD3 for 1,25(OHhD3 production, the processes by which 
1,25(OH}2D, is produced and catabolized are tightly regulated and 
coupled to the differentiation process of these cells [7] . However, in 
vivo the kidney serves as the major source of 1,25(OHhD, produc-
tion, raising the question of whether this process occurs in intact 
skin. 
Extrarenal production of 1,25(OHhD has been demonstrated in 
both anephric humans [8,9] and pigs [10], although the tissue(s) 
responsible has not been established. Immediately folJowing acute 
nephrectomy, however, little 1,25(OHhD3 production can be ob-
served [11,12]. Part of the explanation for this apparent discrepancy 
may lie in the exquisite sensitivity of the 250HD3-1-hydroxylase in 
keratinocytes to the inhibitory action of exogenous 1,25(OH)2D3. 
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pig skin and between pig skins; maximum production 
of 1,25(OH)zD3 in these experiments was 8 pg/min. 
24,25(OHhD3 production was higher than 1,25(OHhD3 
production, reaching a maximum rate of 180 pg/min. Con-
sidering that the production rate of 1,25(OHhD3 in humans 
is 1.25 ng/min and that a 48-cm2 skin flap represents 1/350 
the surface area of a human, and assuming that human and pig 
skin make 1,25(OH)2D3 at comparable rates, one can deter-
mine that the skin has the potential to maintain near-normal 
levels of 1,25(OH)2D3 in the absence ofkidneys when pro-
vided with adequate substrate. Key words: 1,25 (OH) 2DJ/ 
24,25 (OH) 2DJ/pig/skil'l/keratil1ocytes/perfusiol1. ] Invest Der-
matott 02:796 -798, 1994 
Incubation ofkeratinocytes with exogenous 1,25(OH)2D3 inhibits 
l,25{OH)2D3production and stimulates 24,25(OH)zD3 production 
[4]. The half-maximally effective 1,25(OHhD3 concentration for 
these effects is approximately to- II M [1 3]. Similar regulation of 
250HD, metabolism by 1,25(OH)2D3 in renal cells has been ob-
served [14-16]. An important difference in the regulation of 
250HD3 metabolism by 1,25(OH)2D3 between keratinocytes and 
renal cells is that the concentration of 1,25(OH)zD3 required to 
inhibit the 1 hydroxylase and induce the 24 hydroxylase in renal 
cells appears to be several orders of magnitude greater than that 
required for comparable effects in keratinocytes [14-16]. Thus, 
under normal circumstances the production of 1 ,25(OH)2D3 by the 
epidermis might be inhibited by the circulating 1,25(OHhD3Ievels 
but be able to respond when renal production of 1,25(OH)zD3 is 
impaired. The level of 1,25(OHhD3 required to inhibit extrarenal 
1,25(OH)2D3 production is not known. In the study by Shultz et al. 
[12], vitamin D deficiency per se (sufficient to achieve 1,25(OH)2D3 
levels below 5 pgjml) was not sufficient to induce detectable extra-
renaI1,25(OH)2D, production under the conditions of their study. 
Whether similarly low levels would suppress 1,25(OHhD3 pro-
duction in other species such as humans and pigs is not known. 
To establish the possibility that skin could contribute to extrare-
nal production of 1,25(OH)2D3 we examined 1,25(OH)zD3 pro-
duction by skin flaps from vitamin D-replete pigs perfused with 
serum-free media. Our data indicate that the skin can produce 
1,25(OHhD3, and that production appears to increase with time of 
perfusion with a medium devoid of exogenous 1,25(OHhD3. 
MATERIALS AND METHODS 
The isolated perfused porcine skin flap model developed by Riviere et at [1 7) 
was used. A single-pedicle, axial-pattern, island-tubed skin flap is created in 
crossbred Yorkshire weanling pigs. After 2 d the flap is removed from the 
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pig, cannulated, and transferred to a tcmperature-rcgulated perfusion 
chamber for the study. Previous studies with this model have documented 
that the tissue remains viable as assessed by glucose utilization, lactate pro-
duction, lack of LDH release into the perfusate, and preservation of normal 
morphology by light and electron microscopic observations [17,18]. The 
flaps were perfused with Krebs-Ringer bicarbonate buffer, pH 7.4, contain-
ing 5 rnM ~l~cose, 45 gil albun:lln, various antibiotics (gentamicin, ampho-
tericin, penlCIllll1 G), and heparIn 5000 fl./I as prevIously descnbed [17] , but 
to which 250HD) was added to a final concentration of 1.5 X to- 8 M. 
Perfusion continued for 8 h at 1 ml / min; 15-ml fractions were collected. 
Pressure, flow, pH, and skin color were monitored throughout. 
The collected fractions from the perfusion plus aliquots of the venous and 
arterial reservoirs were extracted by the method of Bligh and Dyer [19]. The 
vitamin D metabolites in the organic phasc were separated by high-perfor-
mance liquid chromatography (HPLC) using a Zorbax-Sil column (DnPont, 
Wilmington, DE) and a concave gradient of hexane: isopropanol (97 : 3 to 
90: 10) as previously described [3]. The 1,25(OH),D) and 250HD) peaks 
were collected and assayed as previously described [20]. Fifteen-milliliter 
aliquots from the arterial and venous reservoirs (which had not been perfuscd 
through the pig skin) served as the negative controls for the assay. The 
24,25(OH),D) peak was rechromatographed using the same column but 
eluted with dichloromethane: isopropanol (98: 2) prior to assay [20] . For 
selected samples, the 1,25(OH),D) peak was further chromatographed 
using a Zorbax-Sil column eluted with dichloromcthane: isopropanol 
(96: 4) or using a Cl8 u-Bondapak column (Waters, Milford, MA) eluted 
with methanol: water (75: 25) as descnbed preVIOusly [3]. 
RESULTS 
Production of 1,25(OH)zD3 by thc flaps from two pigs is shown in 
Fig 1. The upper panel shows the amount of 1,25(OH)zD3 recov-
ered in each fraction . The lower panels show the accumulated 
amount of 1,25(OH)zD3 produced. Pig flap 249 produces very little 
1,25(OH)zD) for the first 4 h, but during the second half of the 
perfusion, l,25(OH)zD3 production increases to approximately 7 
pg/ min. In contrast, pig flap 250 produces approximately 2 - 3 pg/ 
min for the first 2.5 h, stops producmg dUring the subsequent 2.5 h, 
then restarts after 5 h , reaching a peak of 8 pg/ min by the end of the 
8-h perfusion. This pattern of increasing 1,25(OH)zD) production 
with time of perfusion was seen in other pig flaps (data not shown), 
although the levels achieved were less impressive. 
Authenticity of the 1,25(OH)zD3 produced was documented by 
evaluating four samples expected to contain high levels of 
1,25(OH)zD3. These were chromatographed successively using 
three different systems beginning with a hexane: isopropanol gra-
dient, followed by an isocratic dichloromethane : isopropanol elu-
tion, and finally by a reverse-phase methanol: water system. Fol-
lowing each step aliquots were taken for assay of the 1,25(OH)zD3 
content. The results show that following the hexane: isopropanol 
gradient the 1,25(OH)zD3 level in the four samples was 101 ± 
23 pg; following the dichloromethane: isopropanol step the level 
was 92 ± 47 pg; following the reverse-phase system the level was 
89 ± 43 pg. These are not significantly different. Thus, by this 
criterion the 1,25(OH)zD) produced by the pig skin is authentic ;ll1d 
not a cross-reacting substance in the assay. 
The amount of 24,25(OH)zD3 produced by the pig skin was 
higher than that of l,25(OH)2D). The results from pig skin 249 are 
shown in Fig 2. In this case only every fourth sample was measured. 
The level of 250HD) in these fractions is also shown in the figure. 
24,25(OH)zD3 production ranged from 45 to 180 pg/min and 
showed no obvious trend, unlike the increasi11g rate of 
1,25(OH)zD3 production by this pig skin flap. As expected, the 
concentration of 250HD3 remained fairly constant throughout the 
perfusion at 16 nM (6.4 ng/ml). 
DISCUSSION 
Human keratinocytes in culture are capable of producing 
1,25(OH)zD3 [3,4]. The rate at which l,25(OH)2D3 production 
occurs is linked to their state of differentiation. Maximal 
1,25(OH)zD3 production occurs just prior to confluence, and falls 
off as the cells differentiate [21]. As 1,25(OH)zD3 production de-
clines, 24,25(OH)2D3 production increases [21] . The process of 
1,25(OH)zD) and 24,25(OH)2D3 production in keratinocytes is 
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also subject to feedback regulation with inhibition of the I-hydrox-
ylase and induction of the 24-hydroxylase at pmolar concentrations 
of exogenous 1,25(OHhD3 [4,13]. Although not yet proven con-
clusively, the inhibition ofl,25(OH)2D3 production and the induc-
tion of 24,25(OH)2D3 production by exogenous 1,25(OHhD) in 
the kidney is thought to involve changes in enzyme synthesis [14-
16]; similar data exist for the keratinocyte [4] . Inhibition of 
l,25(OH)2D3 production occurs more rapidly (within 4 h) than 
induction of 24,25(OH)2D3 production in the kidney [14], as well 
as in the keratinocyte [13] . 
The known regulation of vitamin D metabolism by differentia-
tion and exogenous 1,25(OH)zD3 in the cultured keratinocyte may 
help explain the observations made for 1,25(OH)zDJ <illd 
24,25(OH)2D3 production in the pig skin flap. As a well-differen-
tiated tissue perfused with blood containing approximately 10-7 M 
250HD3 and 10- 10 M 1,25(OH)2D3 prior to the ill vitro perfusion 
study, the skin flap would be expected to have a higher 24-hydrox-
ylase activity than l-hydroxylase activity. This was observed, as 
l,25(OH)zD3 production was initially undetectable in pig skin 249 
and was less than 3 pg/min in pig skin 250, compared to a 
24,25(OH)2D3 production rate of 50 pg/min in pig skin 249. As 
perfusion continued with serum-free medium (i.e. , no exogenous 
1,25(OH)zD3)' the rate of 1,25(OH)2DJ production increased in 
both skin flaps after 4 h . This was not accompanied by a clear de-
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Figure 1. Production of 1,25(OH),D) by pig skin. Two pig skin flaps (249 
and 250) were perfused with 250HD), and the release of 1,25(OH),D) into 
the perfusate was measured as a function of time. In A, levels of 
1,25{OH)2D3 in individual fractions are shown; in B the cumulative produc-
tion of 1,25(OH),D3 is depicted. 
798 BIKLE ET AL 
250HO ngl15m i 24.250 ngl15min 










O ~------------------------------------------- O 














5 6 7 a 
Figure 2. Production of 24.25(OH),D, by pig skin. The release of 
24.25(OH),D, into the perfusate from pig skin flap 249 (see Fig 1 legend) 
was measured in every fourth fraction. Levels in individual fractions are 
shown in (Aj. the cumulative production of24.25(OH),D, is shown inB. In 
addition. the 250HD, content was measured in these same fractions to verify 
the constancy of the perfusion. and the results are shown in A. 
crease in 24.25(OHlzDJ production. which may have been seen if it 
had been possible to extend the perfusion beyond 8 h. 
Using a model that simulates the irl vivo sit).lation. this study 
documents that 1.25(OHhDJ production occurs in intact skin. As 
predicted from studies with keratinocytes in culture. an intact. well-
differentiated epidermis is more likely to produce 24,25(OHlzDJ 
than 1,25(OHhDJ. However, if renal production of 1,25(OHhDJ 
is eliminated. as in severe chronic renal failure or following bilateral 
nephrectomy, the skin appears to be capable of contributing to ex-
trarenal 1.25(OHlzDJ production. In this study the pig skin flaps 
were 48 cm2 in size. This represents approximately 1/350 the sur-
face of the human. Considering that 1,25(OHhDJ production in 
the human is approximately 1.25 ng/min [22]. the ability of the 
flaps to produce up to 8 pg/min suggests that the skin may account 
for most of the extrarenal production of 1.25(OH)2DJ' Further-
more. even though the skin may not contribute substantially to the 
circulating pool of 1.25(OHlzDJ in the normal state. it still may 
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produce enough for its own paracrine or autocrine requirements 
with respect to modulating keratinocyte differentiation. 
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